Show simple item record

dc.contributor.advisorMemar, Mohammad Yousef
dc.contributor.advisorHassani, Akbar
dc.contributor.authorHatami, Asma
dc.date.accessioned2024-10-06T06:09:59Z
dc.date.available2024-10-06T06:09:59Z
dc.date.issued2024en_US
dc.identifier.urihttps://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/71368
dc.description.abstractEnterococci are cocci and facultative anaerobes that are frequently isolated from hospital infections. Vancomycin-resistant Enterococcus isolates are resistant to most antibiotics, and limited options are available to treat infections caused by these strains. One of the treatment solutions to overcome vancomycin-resistant Enterococcus strains is to use a combination of two or more different antibiotics. The purpose of this study is to investigate the effects of combinations of rifampin and vancomycin and fosfomycin and vancomycin in laboratory conditions against vancomycin-resistant Enterococcus isolates. Methods: Clinical specimens were inoculated on specific growth medium and bacterial isolates were identified using standard microbiological methods. Antibiotic resistance patterns of isolates were determined by disk diffusion method, and minimum inhibitory concentration was determined by microbroth dilution method. The synergistic effects of the studied compounds were determined by determining the FIC index using the Checker Board method. Results: In the present study, high levels of antibiotic resistance were observed. None of the studied isolates were resistant to linezolid. Antimicrobial antagonism effects were not observed in any of the combination. The most synergistic effects were in the combination of fosfomycin and necomycin, followed by rifampin and vancomycin.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Medicineen_US
dc.relation.isversionofhttps://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/71367en_US
dc.subjectEnterococcusen_US
dc.subjectvancomycinen_US
dc.subjectfosfomycinen_US
dc.subjectsynergyen_US
dc.titleAssessment of antibiotic sensitivity as single agent and combination of antibiotics against vancomycin-resistant Enterococci (VRE), isolated from clinical specimens collected from Sina Hospital, Tabriz during 2021-2022en_US
dc.typeThesisen_US
dc.contributor.supervisorHassani, Alka
dc.contributor.supervisorVarshochi, Mojtaba
dc.identifier.docno6011694en_US
dc.identifier.callno11694en_US
dc.description.disciplineMedicineen_US
dc.description.degreeMD Degreeen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record